A Gordon Smith

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Gestational Age

Replacement Therapy

Binding Protein

Myasthenia Gravis

Top Venues

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy 41 (6) (2024)
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy (2024)
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy 41 (6) (2024)
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy 41 (6) (2024)
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven Guenther Meuth, Tobias Ruck, A Gordon Smith, Danielle H Bodicoat, Maria De Francesco, Sergio Iannazzo
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison. Advances in therapy 41 (6) (2024)
A Gordon Smith
Maslow's hammer and nerve conduction studies: How best to use a powerful tool in the evaluation and treatment of diabetic neuropathy? Muscle & nerve (2023)